Trident Texofab Share Price History and Returns 2017 to 2024
Trident Texofab Limited | |||
 | Symbol: TTFL | ||
| Price: ₹107.15 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Trident Texofab Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Trident Texofab Recent Performance
- 3: Trident Texofab Stock Price Chart From 2017 to 2024
- 4: Trident Texofab Stock Price History Table From 2017 to 2024
- 5: Analyzing the Impact of Investing in Trident Texofab
- 5.1: Trident Texofab Stock Returns In Last 5 Years
- 5.2: Trident Texofab Stock VS FD (Normal) VS FD (Compounding)
Trident Texofab Stock Highlights
As of Thu 21 Nov 2024, Trident Texofab Stock price is ₹107.15 which is ₹13.85 below 52-week high of ₹121 and ₹71.00 above 52-week low of ₹36.15
52-Week High Low
- Trident Texofab 52-Week High is ₹121 occured on Tue 29 Oct 2024
- Trident Texofab 52-Week Low is ₹36.15 occured on Wed 03 Jul 2024
All Time High
- The all-time high or the highest price that Trident Texofab stocks have ever touched was ₹206 and this occurred on Thu 01 Sep 2022.
- The highest closing price at which Trident Texofab stocks have ever closed was ₹131.6 recorded on Mon 01 Aug 2022.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Trident Texofab Recent Performance
Over the past 20 trading days, the value of Trident Texofab's stock has increased by ₹32.26 (+43.08%). On 17 Oct 2024, its one share was worth ₹74.89 and by 21 Nov 2024, the value jumped to ₹107.15. During this period it created a highest high of ₹121.00 and lowest low of ₹74.89.
Below Image represents line chart of daily close price of Trident Texofab, helping you visualize how the price has changed day by day.
Trident Texofab Stock Price Chart From 2017 to 2024
Trident Texofab Stock Price History Table From 2017 to 2024
| Year | Trident Texofab | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2017 | ₹40.13 | - | ↑ ₹43.20 ↓ ₹17.08 |
| 2018 | ₹40.63 | 1.2% | ↑ ₹61.35 ↓ ₹33.75 |
| 2019 | ₹39.58 | -2.6% | ↑ ₹47.08 ↓ ₹31.67 |
| 2020 | ₹30.95 | -21.9% | ↑ ₹49.50 ↓ ₹24.00 |
| 2021 | ₹47.75 | 54.2% | ↑ ₹54.00 ↓ ₹22.40 |
| 2022 | ₹93.35 | 95.4% | ↑ ₹206 ↓ ₹46.10 |
| 2023 | ₹63.29 | -32.3% | ↑ ₹95.15 ↓ ₹52.26 |
| 2024 | ₹107.15 | 69.3% | ↑ ₹107 ↓ ₹107 |
Analyzing the Impact of Investing in Trident Texofab
Trident Texofab Stock price in the year 2017 was ₹40.13. If you had invested ₹10,000 in Trident Texofab Stock in 2017, in 7 years, your investment would have grown to ₹26,700 by the end of 2024. This represents a positive return of 167% from 2017 to 2024, with a compound annual growth rate (CAGR) of 15%.
Trident Texofab Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: 206.00 and lowest was: 22.40
- Trident Texofab Stock price in 2019 was 39.58
- By 2024, its stock price rose to 107.15
- It gave a positive return of over 170% with a CAGR of 22% over the last 5 years
- If you had invested 10,000 in Trident Texofab in 2019 then in 5 years, your investment would have grown to 27,071 by 2024, which is 2.7 times of your initial investment.
Trident Texofab Stock VS FD (Normal) VS FD (Compounding)
You might wonder which option is better: Trident Texofab stocks, fixed deposits (FDs) or compounding FDs. Let’s compare them and see how they differ.To help you make a well-informed decision, we have prepared a handy table that compares the returns of Trident Texofab Stock with both FD choices over time.
If you invested ₹10,000 each in these 3 options in null:
| Year | Trident Texofab Investment | FD Normal Investment | FD Compond Investment |
|---|---|---|---|
| 2017 | ₹10,000 | ₹10,000 | ₹10,000 |
Then today, your investment would have become this much in each option: | |||
| 2024 | ₹26,585.51 | ₹14,200.00 | ₹15,036.30 |
Note: The Stock price data displayed on this web page has been adjusted for any bonus Stocks or Stock splits that occurred over time.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
